MyAverix Finance
US · Healthcare
Qilian International Holding Group Limited (BGM)
Drug Manufacturers - Specialty & Generic
Qilian International Holding Group Limited (BGM) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BGM
Qilian International Holding Group Limited (BGM) — FAQ
What is BGM's P/E ratio?
The price-to-earnings (P/E) ratio for Qilian International Holding Group Limited (BGM) is 18.00 (data as of 2026-03-23).
Does Qilian International Holding Group Limited pay a dividend?
Dividend yield is not available in the current snapshot for Qilian International Holding Group Limited (BGM). Check the MyAverix Finance app for the latest dividend data.
What sector is Qilian International Holding Group Limited in?
Qilian International Holding Group Limited (BGM) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is BGM listed on?
BGM is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.